214 related articles for article (PubMed ID: 25004249)
21. Primary aldosteronism.
Gordon RD
J Endocrinol Invest; 1995; 18(7):495-511. PubMed ID: 9221268
[TBL] [Abstract][Full Text] [Related]
22. [Familial hypocalciuric hypercalcemia: a new mutation].
Ubetagoyena Arrieta M; Castaño González L; Pérez de Nanclares Leal G; Arruebarrena Lizarraga D; Imaz Murguiondo M; Areses Trapote R
An Pediatr (Barc); 2011 Jan; 74(1):47-50. PubMed ID: 21185797
[TBL] [Abstract][Full Text] [Related]
23. Familial hypocalciuric hypercalcemia and calcium sensing receptor.
Mrgan M; Nielsen S; Brixen K
Acta Clin Croat; 2014 Jun; 53(2):220-5. PubMed ID: 25163238
[TBL] [Abstract][Full Text] [Related]
24. A novel mutation in calcium-sensing receptor gene associated to hypercalcemia and hypercalciuria.
Mastromatteo E; Lamacchia O; Campo MR; Conserva A; Baorda F; Cinque L; Guarnieri V; Scillitani A; Cignarelli M
BMC Endocr Disord; 2014 Oct; 14():81. PubMed ID: 25292184
[TBL] [Abstract][Full Text] [Related]
25. [Familial hypocalciuric hypercalcemia: two case reports (author's transl)].
Sereni D; Chevalier P; Cremer GA; Boissonnas A; Dubost C; Laroche C
Ann Med Interne (Paris); 1982; 133(4):281-4. PubMed ID: 7114660
[TBL] [Abstract][Full Text] [Related]
26. Heterozygous Mutation (Q459R) in the Calcium-Sensing Receptor Gene Causes Familial Hypocalciuric Hypercalcemia 1 (FHH1).
Boisen IM; Mos I; Lerche-Black EM; Juul A; Bräuner-Osborne H; Blomberg Jensen M
J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 32160303
[TBL] [Abstract][Full Text] [Related]
27. Familial Hypocalciuric Hypercalcemia Type 1 and Autosomal-Dominant Hypocalcemia Type 1: Prevalence in a Large Healthcare Population.
Dershem R; Gorvin CM; Metpally RPR; Krishnamurthy S; Smelser DT; Hannan FM; Carey DJ; Thakker RV; Breitwieser GE;
Am J Hum Genet; 2020 Jun; 106(6):734-747. PubMed ID: 32386559
[TBL] [Abstract][Full Text] [Related]
28. Identification and functional analysis of a novel CaSR mutation in a family with familial hypocalciuric hypercalcemia.
Kim ES; Kim SY; Lee JY; Han JH; Sohn TS; Son HS; Moon SD
J Bone Miner Metab; 2016 Nov; 34(6):662-667. PubMed ID: 26386835
[TBL] [Abstract][Full Text] [Related]
29. Novel inactivating mutation of the calcium-sensing receptor in a young woman with mild hypercalcaemia.
Kim DD; Que L; Raizis AM; Florkowski CM
Intern Med J; 2014 Apr; 44(4):413-6. PubMed ID: 24754691
[TBL] [Abstract][Full Text] [Related]
30. New mutation in the CASR gene in a family with familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism (NSHPT).
Rodrigues LS; Cáu AC; Bussmann LZ; Bastida G; Brunetto OH; Corrêa PH; Martin RM
Arq Bras Endocrinol Metabol; 2011 Feb; 55(1):67-71. PubMed ID: 21468522
[TBL] [Abstract][Full Text] [Related]
31. Familial hyperaldosteronism type III a novel case and review of literature.
Pons Fernández N; Moreno F; Morata J; Moriano A; León S; De Mingo C; Zuñiga Á; Calvo F
Rev Endocr Metab Disord; 2019 Mar; 20(1):27-36. PubMed ID: 30569443
[TBL] [Abstract][Full Text] [Related]
32. Misleading localization by
Mukhtar NN; Abouzied MEM; Alqahtani MH; Hammami MM
BMC Endocr Disord; 2021 Jan; 21(1):20. PubMed ID: 33499837
[TBL] [Abstract][Full Text] [Related]
33. Outcome of Clinical Genetic Testing in Patients with Features Suggestive for Hereditary Predisposition to PTH-Mediated Hypercalcemia.
Khairi S; Osborne J; Jacobs MF; Clines GT; Miller BS; Hughes DT; Else T
Horm Cancer; 2020 Oct; 11(5-6):250-255. PubMed ID: 32761341
[TBL] [Abstract][Full Text] [Related]
34. Primary Aldosteronism: KCNJ5 Mutations and Adrenocortical Cell Growth.
Yang Y; Gomez-Sanchez CE; Jaquin D; Aristizabal Prada ET; Meyer LS; Knösel T; Schneider H; Beuschlein F; Reincke M; Williams TA
Hypertension; 2019 Oct; 74(4):809-816. PubMed ID: 31446799
[TBL] [Abstract][Full Text] [Related]
35. Mutations in UCP2 in congenital hyperinsulinism reveal a role for regulation of insulin secretion.
González-Barroso MM; Giurgea I; Bouillaud F; Anedda A; Bellanné-Chantelot C; Hubert L; de Keyzer Y; de Lonlay P; Ricquier D
PLoS One; 2008; 3(12):e3850. PubMed ID: 19065272
[TBL] [Abstract][Full Text] [Related]
36. Calcimimetic Use in Familial Hypocalciuric Hypercalcemia-A Perspective in Endocrinology.
Marx SJ
J Clin Endocrinol Metab; 2017 Nov; 102(11):3933-3936. PubMed ID: 28945857
[TBL] [Abstract][Full Text] [Related]
37. Parathyroidectomy in familial hypercalcemia with clinical characteristics of primary hyperparathyroidism and familial hypocalciuric hypercalcemia.
Szabo E; Hellman P; Lundgren E; Carling T; Rastad J
Surgery; 2002 Mar; 131(3):257-63. PubMed ID: 11894029
[TBL] [Abstract][Full Text] [Related]
38. KCNJ5 mutations in the National Institutes of Health cohort of patients with primary hyperaldosteronism: an infrequent genetic cause of Conn's syndrome.
Xekouki P; Hatch MM; Lin L; Rodrigo de A; Azevedo M; de la Luz Sierra M; Levy I; Saloustros E; Moraitis A; Horvath A; Kebebew E; Hoffman DA; Stratakis CA
Endocr Relat Cancer; 2012 Jun; 19(3):255-60. PubMed ID: 22323562
[TBL] [Abstract][Full Text] [Related]
39. Identification and Functional Characterization of a Calcium-Sensing Receptor Mutation in an Infant with Familial Hypocalciuric Hypercalcemia.
Papadopoulou A; Gole E; Melachroinou K; Meristoudis C; Siahanidou T; Papadimitriou A
J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):341-6. PubMed ID: 27087013
[TBL] [Abstract][Full Text] [Related]
40. Cinacalcet Treatment in an Adolescent With Concurrent 22q11.2 Deletion Syndrome and Familial Hypocalciuric Hypercalcemia Type 3 Caused by AP2S1 Mutation.
Tenhola S; Hendy GN; Valta H; Canaff L; Lee BS; Wong BY; Välimäki MJ; Cole DE; Mäkitie O
J Clin Endocrinol Metab; 2015 Jul; 100(7):2515-8. PubMed ID: 25993639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]